Rhythm Pharmaceuticals, Inc. (RYTM)
Rhythm Pharmaceuticals Market Cap : 8.088B for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 7.450B |
| November 13, 2026 | 7.973B |
| November 12, 2026 | 7.615B |
| November 11, 2026 | 7.774B |
| November 10, 2026 | 7.898B |
| November 09, 2026 | 7.898B |
| November 06, 2026 | 7.783B |
| November 05, 2026 | 7.279B |
| November 04, 2026 | 7.672B |
| November 03, 2026 | 5.992B |
| November 02, 2026 | 6.477B |
| October 30, 2026 | 6.416B |
| October 29, 2026 | 6.451B |
| October 28, 2026 | 6.329B |
| October 27, 2026 | 6.344B |
| October 26, 2026 | 6.157B |
| October 23, 2026 | 6.143B |
| October 22, 2026 | 6.255B |
| October 21, 2026 | 6.099B |
| October 20, 2026 | 6.207B |
| October 19, 2026 | 6.072B |
| October 16, 2026 | 5.930B |
| October 15, 2026 | 6.054B |
| October 14, 2026 | 5.967B |
| October 13, 2026 | 5.960B |
| Date | Value |
|---|---|
| October 12, 2026 | 6.181B |
| October 09, 2026 | 6.247B |
| October 08, 2026 | 6.169B |
| October 07, 2026 | 6.087B |
| October 06, 2026 | 6.247B |
| October 05, 2026 | 6.362B |
| October 02, 2026 | 6.388B |
| October 01, 2026 | 6.428B |
| September 30, 2026 | 6.552B |
| September 29, 2026 | 6.586B |
| September 28, 2026 | 6.783B |
| September 25, 2026 | 6.789B |
| September 24, 2026 | 6.765B |
| September 23, 2026 | 6.761B |
| September 22, 2026 | 6.831B |
| September 21, 2026 | 6.801B |
| September 18, 2026 | 6.724B |
| September 17, 2026 | 6.814B |
| September 16, 2026 | 6.745B |
| September 15, 2026 | 6.659B |
| September 14, 2026 | 7.050B |
| September 11, 2026 | 7.206B |
| September 10, 2026 | 7.033B |
| September 09, 2026 | 6.955B |
| September 08, 2026 | 7.006B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Arrowhead Pharmaceuticals, Inc. | 6.070B |
| BioMarin Pharmaceutical, Inc. | 11.33B |
| Cytokinetics, Inc. | 7.199B |
| Exelixis, Inc. | 16.76B |
Market Cap Related Metrics
| PS Ratio | 28.31 |
| Price to Book Value | 91.95 |
| Price | 116.69 |
| Earnings Yield | -2.50% |